Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.

Authors:
Dolores Siedlecki-Wullich Judit Català-Solsona Cristina Fábregas Isabel Hernández Jordi Clarimon Alberto Lleó Merce Boada Carlos A Saura José Rodríguez-Álvarez Alfredo J Miñano-Molina

Alzheimers Res Ther 2019 05 15;11(1):46. Epub 2019 May 15.

Institut de Neurociències and Dpt. Bioquímica i Biología Molecular, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès, Spain.

Background: Several evidences suggest that failure of synaptic function occurs at preclinical stages of Alzheimer's disease (AD) preceding neuronal loss and the classical AD pathological hallmarks. Nowadays, there is an urgent need to identify reliable biomarkers that could be obtained with non-invasive methods to improve AD diagnosis at early stages. Here, we have examined plasma levels of a group of miRNAs related to synaptic proteins in a cohort composed of cognitive healthy controls (HC), mild cognitive impairment (MCI) and AD subjects.

Methods: Plasma and brain levels of miRNAs were analysed in two different cohorts including 38 HC, 26 MCI, 56 AD dementia patients and 27 frontotemporal dementia (FTD) patients. D'Agostino and Pearson and Shapiro-Wilk tests were used to evaluate data normality. miRNA levels between groups were compared using a two-sided nonparametric Mann-Whitney test and sensitivity and specificity was determined by receiver operating characteristic curve analysis.

Results: Significant upregulation of miR-92a-3p, miR-181c-5p and miR-210-3p was found in the plasma of both MCI and AD subjects. MCI patients that progress to AD showed higher plasma levels of these miRNAs. By contrast, no changes in miR-92a-3p, miR-181c-5p or miR-210-3p levels were observed in plasma obtained from a cohort of FTD.

Conclusion: Our study shows that plasma miR-92a-3p, miR-181c-5p and miR-210-3p constitute a specific molecular signature potentially useful as a potential biomarker for AD.

Download full-text PDF

 Source
http://dx.doi.org/10.1186/s13195-019-0501-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521366PMC
May 2019

Publication Analysis

Top Keywords

mir-92a-3p mir-181c-5p
12
mir-181c-5p mir-210-3p
12
plasma levels
8
levels mirnas
8
synaptic function
8
alzheimer's disease
8
plasma
7
levels
5
pearson shapiro-wilk
4
dementia ftd
4
patients d'agostino
4
d'agostino pearson
4
ftd patients
4
tests evaluate
4
levels groups
4
groups compared
4
compared two-sided
4
two-sided nonparametric
4
mirna levels
4
normality mirna
4

Altmetric Statistics


Show full details
32 Total Shares
1 Facebook Pages
5 News Outlets
20 Tweets
26 Citations
Get 20% Off Journals at LWW.com

Similar Publications

Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.

Authors:
Dolores Siedlecki-Wullich Judit Català-Solsona Cristina Fábregas Isabel Hernández Jordi Clarimon Alberto Lleó Merce Boada Carlos A Saura José Rodríguez-Álvarez Alfredo J Miñano-Molina

Alzheimers Res Ther 2019 05 15;11(1):46. Epub 2019 May 15.

Institut de Neurociències and Dpt. Bioquímica i Biología Molecular, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès, Spain.

Background: Several evidences suggest that failure of synaptic function occurs at preclinical stages of Alzheimer's disease (AD) preceding neuronal loss and the classical AD pathological hallmarks. Nowadays, there is an urgent need to identify reliable biomarkers that could be obtained with non-invasive methods to improve AD diagnosis at early stages. Here, we have examined plasma levels of a group of miRNAs related to synaptic proteins in a cohort composed of cognitive healthy controls (HC), mild cognitive impairment (MCI) and AD subjects. Read More

View Article and Full-Text PDF
May 2019
Similar Publications

The regulation of miRNAs by reconstituted high-density lipoproteins in diabetes-impaired angiogenesis.

Authors:
Samuel T Hourigan Emma L Solly Victoria A Nankivell Anisyah Ridiandries Benjamin M Weimann Rodney Henriquez Edward R Tepper Jennifer Q J Zhang Tania Tsatralis Zoe E Clayton Laura Z Vanags Stacy Robertson Stephen J Nicholls Martin K C Ng Christina A Bursill Joanne T M Tan

Sci Rep 2018 09 11;8(1):13596. Epub 2018 Sep 11.

The Heart Research Institute, Sydney, Australia.

Diabetic vascular complications are associated with impaired ischaemia-driven angiogenesis. We recently found that reconstituted high-density lipoproteins (rHDL) rescue diabetes-impaired angiogenesis. microRNAs (miRNAs) regulate angiogenesis and are transported within HDL to sites of injury/repair. Read More

View Article and Full-Text PDF
September 2018
Similar Publications

Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.

Authors:
Keren Regev Brian C Healy Fariha Khalid Anu Paul Renxin Chu Shahamat Tauhid Subhash Tummala Camilo Diaz-Cruz Radhika Raheja Maria A Mazzola Felipe von Glehn Pia Kivisakk Sheena L Dupuy Gloria Kim Tanuja Chitnis Howard L Weiner Roopali Gandhi Rohit Bakshi

JAMA Neurol 2017 03;74(3):275-285

Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Partners Multiple Sclerosis Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts4Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Importance: MicroRNAs (miRNAs) are promising multiple sclerosis (MS) biomarkers. Establishing the association between miRNAs and magnetic resonance imaging (MRI) measures of disease severity will help define their significance and potential impact.

Objective: To correlate circulating miRNAs in the serum of patients with MS to brain and spinal MRI. Read More

View Article and Full-Text PDF
March 2017
Similar Publications